Skip to main content
. 2020 Oct 1;31(4):2289–2302. doi: 10.1007/s00330-020-07303-9

Fig. 6.

Fig. 6

Comparison of disease-free survival (DFS) according to the serum AFP level in LR-5a (a), LR-5b (b), and LR-5c (c) subgroups. There were no significant differences in DFS between patients with serum AFP level > 400 ng/mL and those with serum AFP level ≤ 400 ng/mL for three subgroups